Paroxetine Tablet, Film Coated
Product Images NDC 68788-8777
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Paroxetine (NDC 68788-8777). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Paroxetine HCl Tablets Usp 20mg (Image 03)
This text provides information about Paroxetine HCI tablets, a medication used to treat various conditions. It includes details such as the dosage, generic name, manufacturer, and instructions for use. The tablets are film-coated and contain paroxetine hydrochloride. The text emphasizes the importance of not transferring the medication to anyone other than the prescribed patient due to federal law regulations.*
Figure 1. Impact Of Paroxetine On The Pharmacokinetics Of Co-administered Drugs (log Scale) (Image 06)
This text seems to provide information about specific drug interactions involving medications such as Pimozide, Desipramine, Propranolol, Digoxin, and Phenytoin. It appears to mention pharmacokinetic parameters like Cmax and AUC for these drugs, possibly in relation to fold change and 90% confidence intervals. The text also notes changes relative to a reference value. This data could be helpful in assessing the impact of drug interactions on the pharmacokinetics of the mentioned medications.*
Figure 2. Impact Of Co-administered Drugs On The Pharmacokinetics Of Paroxetine (Image 07)
Figure 3. Impact Of Specific Population On The Pharmacokinetics Of Paroxetine (log Scale) (Image 08)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.